RPCI Facility Begins Research Study of a Dendritic Cell Vaccine
A groundbreaking dendritic cell vaccine study is underway at the Center for Immunotherapy at Roswell Park Cancer Institute. Researchers at RCPI began a phase 1…
Roswell Park Cancer Institute News